BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17597167)

  • 1. Inflammation in the nervous system--physiological and pathophysiological aspects.
    Schultzberg M; Lindberg C; Aronsson AF; Hjorth E; Spulber SD; Oprica M
    Physiol Behav; 2007 Sep; 92(1-2):121-8. PubMed ID: 17597167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation in central nervous system injury.
    Allan SM; Rothwell NJ
    Philos Trans R Soc Lond B Biol Sci; 2003 Oct; 358(1438):1669-77. PubMed ID: 14561325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connection between inflammatory processes and transmittor function-Modulatory effects of interleukin-1.
    Spulber S; Schultzberg M
    Prog Neurobiol; 2010 Feb; 90(2):256-62. PubMed ID: 19853010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and autoimmunity as a central theme in neurodegenerative disorders: fact or fiction?
    Clarkson AN; Rahman R; Appleton I
    Curr Opin Investig Drugs; 2004 Jul; 5(7):706-13. PubMed ID: 15298065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke.
    Sarchielli P; Galli F; Floridi A; Floridi A; Gallai V
    Amino Acids; 2003 Dec; 25(3-4):427-36. PubMed ID: 14661102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
    Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-derived cytokines in the nervous system: epigenetic instructive signals or neuropathogenic mediators?
    Ensoli F; Fiorelli V; Muratori DS; De Cristofaro M; Vincenzi L; Topino S; Novi A; Luzi G; Sirianni MC
    Crit Rev Immunol; 1999; 19(2):97-116. PubMed ID: 10352899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and the degenerative diseases of aging.
    McGeer PL; McGeer EG
    Ann N Y Acad Sci; 2004 Dec; 1035():104-16. PubMed ID: 15681803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?
    Marchetti B; Abbracchio MP
    Trends Pharmacol Sci; 2005 Oct; 26(10):517-25. PubMed ID: 16126283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system inflammation in disease related conditions: mechanistic prospects.
    Fung A; Vizcaychipi M; Lloyd D; Wan Y; Ma D
    Brain Res; 2012 Mar; 1446():144-55. PubMed ID: 22342162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.
    Watson GS; Craft S
    J Neurol Sci; 2006 Jun; 245(1-2):21-33. PubMed ID: 16631207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural cell cycle dysregulation and central nervous system diseases.
    Wang W; Bu B; Xie M; Zhang M; Yu Z; Tao D
    Prog Neurobiol; 2009 Sep; 89(1):1-17. PubMed ID: 19619927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications.
    Rothwell N; Allan S; Toulmond S
    J Clin Invest; 1997 Dec; 100(11):2648-52. PubMed ID: 9389726
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxidative stress and the pathogenesis of neurodegenerative disorders.
    Reynolds A; Laurie C; Mosley RL; Gendelman HE
    Int Rev Neurobiol; 2007; 82():297-325. PubMed ID: 17678968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammasome signaling at the heart of central nervous system pathology.
    Chakraborty S; Kaushik DK; Gupta M; Basu A
    J Neurosci Res; 2010 Jun; 88(8):1615-31. PubMed ID: 20127816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of complement in neurodegeneration and neuroinflammation.
    Bonifati DM; Kishore U
    Mol Immunol; 2007 Feb; 44(5):999-1010. PubMed ID: 16698083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic infections and inflammation affect chronic neurodegeneration.
    Perry VH; Cunningham C; Holmes C
    Nat Rev Immunol; 2007 Feb; 7(2):161-7. PubMed ID: 17220915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.